Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Polyplus-transfection licenses ZNA oligonucleotide technology to metabion
April 2010
SHARING OPTIONS:

STRASBOURG, FranceóPolyplus-transfection SA, a developer of solutions for molecular and cellular biology, announced in March that metabion GmbH, a company specialized in custom synthesis of biopolymers, has signed a non-exclusive agreement to manufacture and commercialize Polyplus-transfection's Zip Nucleic Acid (ZNA) oligonucleotides, a new technology that increases affinity for nucleic acids. Under the terms of the license, metabion GmbH has acquired rights to manufacture and commercialize custom ZNA oligonucleotides for research and in vitro diagnostic applications. Financial details were not released.


Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.